CLNS1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.167400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.866000E-01
Normal-vs-Stage2
7.749000E-01
Normal-vs-Stage3
2.783800E-01
Normal-vs-Stage4
3.076200E-01
Stage1-vs-Stage2
8.397200E-01
Stage1-vs-Stage3
2.429000E-01
Stage1-vs-Stage4
3.283200E-01
Stage2-vs-Stage3
1.197820E-01
Stage2-vs-Stage4
2.767200E-01
Stage3-vs-Stage4
8.640000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.207600E-01
Normal-vs-AfricanAmerican
7.319400E-01
Normal-vs-Asian
8.718600E-01
Caucasian-vs-AfricanAmerican
9.608800E-01
Caucasian-vs-Asian
8.493200E-01
AfricanAmerican-vs-Asian
8.301200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.883600E-01
Normal-vs-Female
8.647000E-01
Male-vs-Female
6.720600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.304000E-01
Normal-vs-Age(41-60Yrs)
5.364800E-01
Normal-vs-Age(61-80Yrs)
9.985600E-01
Normal-vs-Age(81-100Yrs)
3.659000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.019800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.697400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.231800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.090100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.120200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.827500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.544400E-01
Normal-vs-Daily Drinker
7.833000E-01
Normal-vs-Weekly Drinker
7.964600E-01
Normal-vs-Occasional Drinker
3.396000E-01
Normal-vs-Social Drinker
8.863400E-01
Non Drinker-vs-Daily Drinker
5.639200E-01
Non Drinker-vs-Weekly Drinker
5.734000E-01
Non Drinker-vs-Occasional Drinker
1.612420E-01
Non Drinker-vs-Social Drinker
8.481600E-01
Daily Drinker-vs-Weekly Drinker
3.807000E-01
Daily Drinker-vs-Occasional Drinker
5.780000E-01
Daily Drinker-vs-Social Drinker
7.653400E-01
Weekly Drinker-vs-Occasional Drinker
6.112400E-02
Weekly Drinker-vs-Social Drinker
5.320200E-01
Occasional Drinker-vs-Social Drinker
3.283200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.012600E-01
Normal-vs-Grade 2
5.046100E-02
Normal-vs-Grade 3
6.228000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.956100E-03
Grade 1-vs-Grade 3
5.014900E-04
Grade 1-vs-Grade 4
3.012600E-01
Grade 2-vs-Grade 3
6.571600E-02
Grade 2-vs-Grade 4
5.046100E-02
Grade 3-vs-Grade 4
6.228000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.664200E-01
Normal-vs-NonDiabetic
7.866000E-01
Diabetic-vs-NonDiabetic
4.757200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.581600E-01
Normal-vs-NoPancreatitis
8.343400E-01
Pancreatitis-vs-NoPancreatitis
2.868200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.040200E-01
Normal-vs-N1
8.485800E-01
N0-vs-N1
3.076800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.026600E-01
Normal-vs-TP53-NonMutant
9.288800E-01
TP53-Mutant-vs-TP53-NonMutant
3.94670000000152E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
